Porównaj metody
Przeglądaj wybrane metody obok siebie; wiersze, które się różnią, są wyróżnione.
| Skala Oceny Przestrzegania Zaleceń Lekowych (MARS)× | Kwestionariusz satysfakcji z leczenia farmakologicznego (TSQM)× | |
|---|---|---|
| Dziedzina | Farmakologia | Farmakologia |
| Rodzina | Process / pipeline | Process / pipeline |
| Rok powstania≠ | 2000 | 2004 |
| Twórca≠ | Kathryn Thompson, Jayashri Kulkarni, and Anthony A. Sergejew | Mary Jo Atkinson and colleagues |
| Typ | Self-report | Self-report |
| Źródło pierwotne≠ | Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247. DOI ↗ | Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Berman, B. M., & Wolpert, B. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel of chronically ill individuals. Health and Quality of Life Outcomes, 2(1), 12. DOI ↗ |
| Inne nazwy | MARS | TSQM |
| Pokrewne | 4 | 4 |
| Podsumowanie≠ | The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors. | The Treatment Satisfaction Questionnaire for Medication (TSQM) is a 14-item generic measure developed by Atkinson and colleagues in 2004 to assess patient satisfaction with medication across diverse therapeutic areas and disease conditions. It measures four key dimensions—Effectiveness, Side Effects, Convenience, and Global Satisfaction—with standardized 0–100 scoring, making it suitable for cross-disease comparison and health economic evaluation. The TSQM has become a standard outcome in pharmaceutical research, clinical trials, and real-world medication effectiveness studies. |
| ScholarGateZbiór danych ↗ |
|
|